INS and diabetes mellitus: These pIPCs were then given to NOD mice before the onset of clinical manifestations of T1D and compared with the group of mice that received MSCs differentiated into insulin-producing cells and controls to compare the efficacy of the two modalities to arrest diabetes in NOD mice.